65,437 trials
Pulmonary Arterial Hypertension
Primary: Effect of Long-term Remodulin Therapy on the 6-Minute Walk Distance (6MWD) — 440.8 Meters
HIV Disease
Primary: Change in Neurometabolites Based on Magnetic Resonance Spectroscopy (MRS) — 19.61; 24.54; 6.71; 12.08 arbitrary units
Hepatitis C Virus Infection
Primary: Percentage of Participants With Sustained Virologic Response 12 Weeks After Discontinuation of Therapy (SVR12) — 91.3 percentage of participants
Metabolic Syndrome
Primary: Mean Increase in High Density Lipoprotein Cholesterol (HDL-C) at Baseline and 12 Weeks — 37.4; 36.2; 40.6; 44.2 mg/dL — p=<0.0001
Adult Male Hypogonadism
Primary: The Percentage of Subjects Whose Average Concentration (Cave(0-24)) Serum Total Testosterone Levels Are ≥300 and ≤1050 ng/dL — 76.1 percentage of subjects
Infections, Streptococcal · Streptococcal Infections
Primary: Concentration of Serotype Ia GBS IgG Levels in Healthy Non-pregnant Women — 6.81; 6.66 µg/mL
Healthy
Primary: Accuracy of Sensor by Arms Calculation — 1.9 % of oxygen saturated hemoglobin
Endometritis · Wound Infection · Abscess
Primary: Participants With Endometritis and/or Wound Infection and/or Other Post-cesarean Infections (Occurring Within 6 Weeks of Delivery) — 119; 62 Participants
Cataracts
Primary: Mean Corneal Incision Size After IOL Implantation (UltraSert, iTec, and iSert) — 2.35; 2.47; 2.54 mm
Cystic Fibrosis
Primary: Neutrophil Delivery to the Oral Mucosa Using a Non-invasive Mouthwash Technique — 6.4; -19.6; -28.4 % change in mean PMN counts: B vs T
Cataract Surgery
Primary: Number of Eyes With Stable IOP — 16; 14 Eyes
Gastroparesis · Gastroesophageal Reflux Disease
Primary: Time to Maximal Omeprazole Concentration (Tmax) — 32; 97 minutes — p=< 0.01
Hypogonadal Males
Primary: Responder Rate: Percentage of Subjects Whose Average Steady State Concentration (Cavg) of Serum Total Testosterone Levels Are Between 300 and 1050 ng/dL Following…
Adult Rhabdomyosarcoma · Childhood Alveolar Rhabdomyosarcoma · Childhood Embryonal Rhabdomyosarcoma
Primary: Feasibility of the Addition of Cixutumumab to Chemotherapy Determined by Patient Enrollment — 0.9390 Proportion of Participants
Brain Injuries
Primary: Cognitive Composite Score for Group of Subjects With TBI and Healthy Controls Matched by Age, Education, and Treatment Group. — 42.750; 50.500; 49.500; 55.000 T-score…